(Q54699349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Elvira Mustać

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Nives Jonjić

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Blazenka Grahovac

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Marija Petković

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

8 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

392-403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062009%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.166

16 January 2020

exact match

0 references

cites work

EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

HER-2/neu and topoisomerase IIalpha--simultaneous drug targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Targeted therapy in breast cancer: the HER-2/neu gene and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

The role of the epidermal growth factor receptor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Nuclear localization of EGF receptor and its potential new role as a transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

PowerMarker: an integrated analysis environment for genetic marker analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Nuclear localization and possible functions of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Nuclear localization and function of polypeptide ligands and their receptors: a new paradigm for hormone specificity within the mammary gland?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cycli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Cytologic evaluation of cyclin D1 expression in primary breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Bcl-2 induces cyclin D1 promoter activity in human breast epithelial cells independent of cell anchorage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021

Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021

Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021

Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021

Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.166

7 January 2021